National Biomedical Research Act

Summary

National Biomedical Research Act This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research. The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 11 December 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 11 December 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 11 December 2019

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.